oleanolic acid has been researched along with Experimental Neoplasms in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; He, K; Liang, Z; Meng, X; Pan, R; Su, J; Wei, G; Zhang, Z | 1 |
| Niu, G; Pei, Y; Sun, L; Wang, D | 1 |
| Dong, L; Li, H; Liu, C; Sun, Z; Wang, L; Wang, Q; Wang, X; Zhang, J | 1 |
| Bi, Y; Liu, XX; Qi, JG; Ren, QW; Tian, JW; Wang, BH; Wang, HB; Wang, X; Yang, YT; Zhai, R | 1 |
| Ding, M; Li, W; Lu, J; Wang, X; Wang, Z; Xu, L; Yuan, W; Zhang, H; Zhang, Y; Zhao, Y | 1 |
| Liby, KT; Ringelberg, CS; Risingsong, R; Royce, DB; Sporn, MB; To, C; Williams, CR | 1 |
| Clapper, ML; Grubbs, CJ; Juliana, MM; Lubet, RA; McCormick, DL; Steele, VE; Townsend, R | 1 |
| Leal, AS; Liby, KT; Pioli, PA; Sporn, MB | 1 |
| Antonia, S; Becerra, CR; Cotter, MJ; Fishman, M; Gabrilovich, DI; Iclozan, C; Lee, JH; Liby, KT; Lu, L; Meyer, C; Nagaraj, S; Rawal, B; Sporn, MB; Weber, H; Youn, JI | 1 |
| Chen, X; Ding, Y; Fang, W; Huang, D; Li, Y; Zhang, W | 1 |
| Fukuda, Y; Matsunaga, S; Sakai, K; Tanaka, R; Tokuda, H | 1 |
| Bansal, MP; Sharma, M; Sharma, PD; Singh, J | 1 |
| Butterworth, KR; Evans, JG; Gaunt, IF; Grasso, P; Phillips, JC | 1 |
| Liu, LS; Wu, FE; Xiao, XH; Zhang, LD; Zheng, RL; Zhu, ZQ | 1 |
14 other study(ies) available for oleanolic acid and Experimental Neoplasms
| Article | Year |
|---|---|
Transcriptome study of oleanolic acid in the inhibition of breast tumor growth based on high-throughput sequencing.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Humans; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Oleanolic Acid; RNA-Seq; Transcriptome | 2021 |
Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Neovascularization, Pathologic; Oleanolic Acid; Signal Transduction; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2; Wound Healing | 2018 |
Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
Topics: Aldehyde Dehydrogenase; Animals; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Interleukin-6; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neoplastic Stem Cells; Oleanolic Acid; Saponins; Signal Transduction; STAT3 Transcription Factor | 2018 |
Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Oleanolic Acid; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
New perspective on the metabolism of AD-1 in vivo: Characterization of a series of dammarane-type derivatives with novel metabolic sites and anticancer mechanisms of active oleanane-type metabolites.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dammaranes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ginsenosides; Humans; Male; Molecular Structure; Neoplasms, Experimental; Oleanolic Acid; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured | 2019 |
Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Dimethyl Fumarate; Female; Fumarates; Gene Expression Regulation, Neoplastic; Imidazoles; Lung Neoplasms; Mice, Inbred Strains; Mice, Knockout; Molecular Targeted Therapy; Neoplasms, Experimental; NF-E2-Related Factor 2; Oleanolic Acid; Oligonucleotide Array Sequence Analysis; Oxidative Stress | 2015 |
5MeCDDO Blocks Metabolic Activation but not Progression of Breast, Intestine, and Tongue Cancers. Is Antioxidant Response Element a Prevention Target?
Topics: Activation, Metabolic; Animals; Antineoplastic Agents; Antioxidant Response Elements; Carcinogens; Disease Progression; Female; Imidazoles; Intestinal Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred AKR; Neoplasms, Experimental; Oleanolic Acid; Rats; Rats, Sprague-Dawley; Tongue Neoplasms | 2016 |
The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer.
Topics: Animals; Granulocyte Colony-Stimulating Factor; Homeodomain Proteins; Humans; Imidazoles; Inflammation; Interleukin-6; Leukocyte Common Antigens; Lipopolysaccharides; Mice; Mice, Knockout; Monocyte Chemoattractant Proteins; Neoplasms, Experimental; Oleanolic Acid; Pancreas; Pancreatic Neoplasms; Pancreatitis, Chronic; Proto-Oncogene Proteins p21(ras); Trans-Activators; Vascular Endothelial Growth Factor A | 2016 |
Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.
Topics: Aged; Aged, 80 and over; Animals; Arginase; Clinical Trials, Phase I as Topic; Dendritic Cells; Female; Humans; Immune Tolerance; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, SCID; Middle Aged; Myeloid Cells; Neoplasms, Experimental; Nitric Oxide; Oleanolic Acid; Prognosis; Reactive Oxygen Species | 2010 |
Anti-tumor activity of a 3-oxo derivative of oleanolic acid.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Survival; DNA Topoisomerases, Type I; Humans; Monophenol Monooxygenase; Neoplasms, Experimental; Oleanolic Acid; Thymidine; Tumor Cells, Cultured | 2006 |
Cancer chemopreventive activity of lupane- and oleanane-type triterpenoids from the cones of Liquidamber styraciflua.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Cell Line; Chromatography, Gel; Humans; Liquidambar; Mice; Neoplasms, Experimental; Oleanolic Acid; Tetradecanoylphorbol Acetate; Triterpenes | 2005 |
Synthesis, cytotoxicity, and antitumor activity of lantadene-A congeners.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Female; Humans; Mice; Neoplasms, Experimental; Oleanolic Acid; Structure-Activity Relationship; Tumor Cells, Cultured | 2007 |
Long-term toxicity study of quillaia extract in mice.
Topics: Animals; Body Weight; Female; Food Additives; Male; Mice; Neoplasms, Experimental; Oleanolic Acid; Organ Size; Plant Extracts; Plants, Edible; Saponins; Time Factors; Triterpenes | 1979 |
[Effects of anemodeanin A on DNA, RNA and protein of tumor cells in vitro and plasma cAMP in mice].
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Ehrlich Tumor; Cyclic AMP; DNA, Neoplasm; Female; Male; Mice; Neoplasm Proteins; Neoplasms, Experimental; Oleanolic Acid; RNA, Neoplasm; Sapogenins; Sarcoma 180 | 1985 |